QQQ   281.68 (-2.07%)
AAPL   142.91 (-2.54%)
MSFT   245.12 (-2.03%)
META   114.12 (-6.79%)
GOOGL   96.98 (-2.51%)
AMZN   88.25 (-3.03%)
TSLA   179.82 (-1.44%)
NVDA   159.87 (-3.75%)
NIO   13.24 (+3.44%)
BABA   91.45 (+1.03%)
AMD   70.27 (-4.55%)
T   19.17 (+2.24%)
MU   53.68 (-0.67%)
CGC   3.61 (-16.44%)
F   13.28 (-0.75%)
GE   85.28 (+0.73%)
DIS   92.29 (-3.79%)
AMC   6.75 (-9.40%)
PYPL   72.23 (-1.89%)
PFE   49.71 (-2.01%)
NFLX   305.56 (-2.25%)
QQQ   281.68 (-2.07%)
AAPL   142.91 (-2.54%)
MSFT   245.12 (-2.03%)
META   114.12 (-6.79%)
GOOGL   96.98 (-2.51%)
AMZN   88.25 (-3.03%)
TSLA   179.82 (-1.44%)
NVDA   159.87 (-3.75%)
NIO   13.24 (+3.44%)
BABA   91.45 (+1.03%)
AMD   70.27 (-4.55%)
T   19.17 (+2.24%)
MU   53.68 (-0.67%)
CGC   3.61 (-16.44%)
F   13.28 (-0.75%)
GE   85.28 (+0.73%)
DIS   92.29 (-3.79%)
AMC   6.75 (-9.40%)
PYPL   72.23 (-1.89%)
PFE   49.71 (-2.01%)
NFLX   305.56 (-2.25%)
QQQ   281.68 (-2.07%)
AAPL   142.91 (-2.54%)
MSFT   245.12 (-2.03%)
META   114.12 (-6.79%)
GOOGL   96.98 (-2.51%)
AMZN   88.25 (-3.03%)
TSLA   179.82 (-1.44%)
NVDA   159.87 (-3.75%)
NIO   13.24 (+3.44%)
BABA   91.45 (+1.03%)
AMD   70.27 (-4.55%)
T   19.17 (+2.24%)
MU   53.68 (-0.67%)
CGC   3.61 (-16.44%)
F   13.28 (-0.75%)
GE   85.28 (+0.73%)
DIS   92.29 (-3.79%)
AMC   6.75 (-9.40%)
PYPL   72.23 (-1.89%)
PFE   49.71 (-2.01%)
NFLX   305.56 (-2.25%)
QQQ   281.68 (-2.07%)
AAPL   142.91 (-2.54%)
MSFT   245.12 (-2.03%)
META   114.12 (-6.79%)
GOOGL   96.98 (-2.51%)
AMZN   88.25 (-3.03%)
TSLA   179.82 (-1.44%)
NVDA   159.87 (-3.75%)
NIO   13.24 (+3.44%)
BABA   91.45 (+1.03%)
AMD   70.27 (-4.55%)
T   19.17 (+2.24%)
MU   53.68 (-0.67%)
CGC   3.61 (-16.44%)
F   13.28 (-0.75%)
GE   85.28 (+0.73%)
DIS   92.29 (-3.79%)
AMC   6.75 (-9.40%)
PYPL   72.23 (-1.89%)
PFE   49.71 (-2.01%)
NFLX   305.56 (-2.25%)
NYSE:PEAK

Healthpeak Properties - PEAK Price Target & Analyst Ratings

$25.81
-0.22 (-0.85%)
(As of 12/6/2022 12:00 AM ET)
Add
Compare
Today's Range
$25.68
$26.25
50-Day Range
$21.61
$26.26
52-Week Range
$21.41
$36.85
Volume
5.24 million shs
Average Volume
4.16 million shs
Market Capitalization
$13.87 billion
P/E Ratio
26.89
Dividend Yield
4.61%
Price Target
$31.27

Healthpeak Properties Consensus Rating and Price Target (2023)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Analyst Rating

Hold
Based on 11 Analyst Ratings

Consensus Analyst Price Target

$31.27
21.17% Upside
High Prediction$40.00
Average Prediction$31.27
Low Prediction$23.00
TypeCurrent
12/6/21 to 12/6/22
1 Month Ago
11/6/21 to 11/6/22
3 Months Ago
9/7/21 to 9/7/22
1 Year Ago
12/6/20 to 12/6/21
Consensus Rating
Hold
Hold
Hold
Hold
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
5 Buy rating(s)
5 Buy rating(s)
3 Buy rating(s)
6 Buy rating(s)
Hold
6 Hold rating(s)
6 Hold rating(s)
7 Hold rating(s)
5 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
1 Sell rating(s)
Consensus Price Target$31.27$32.33$33.18$35.40
Predicted Upside21.17% Upside12.92% Upside10.29% Upside4.59% Upside
Get Healthpeak Properties Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for PEAK and its competitors with MarketBeat's FREE daily newsletter.


PEAK Analyst Ratings By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

PEAK Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Healthpeak Properties Stock vs. The Competition

TypeHealthpeak PropertiesFinance CompaniesS&P 500
Consensus Rating Score
2.45
2.45
2.47
Consensus RatingHoldHoldHold
Predicted Upside21.17% Upside62.84% Upside15.21% Upside
News Sentiment RatingPositive News
Positive News
Neutral News
MarketBeat
Community Rating
Outperform Votes
18
43.90%
Underperform Votes
23
56.10%
Avg. Outperform Votes
149
62.08%
Avg. Underperform Votes
91
37.92%
Avg. Outperform Votes
851
68.08%
Avg. Underperform Votes
399
31.92%

Historical Target Prices and Ratings

DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
11/21/2022Evercore ISI
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeIn-Line ➝ Outperform$28.00+13.59%
11/1/2022Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetEqual Weight$27.00 ➝ $23.00-3.08%
9/28/2022Wolfe Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradePeer Perform ➝ Outperform$27.00+18.42%
9/9/2022Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetOverweight$38.00 ➝ $36.00+35.03%
7/29/2022Mizuho
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetNeutral$37.00 ➝ $29.00+5.49%
7/8/2022Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeNeutral ➝ Buy$33.00 ➝ $31.00+17.42%
6/30/2022Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetHold$33.00 ➝ $26.00+0.62%
6/3/2022Capital One Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
D. Bernstein
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageEqual Weight ➝ Equal Weight$34.00+16.12%
5/19/2022Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeBuy ➝ Neutral$32.00+6.42%
4/4/2022Credit Suisse Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetNeutral$37.00 ➝ $38.00+8.54%
12/20/2021JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeNeutral ➝ Overweight$38.00 ➝ $40.00+14.55%
11/18/2021Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOutperform$39.00 ➝ $40.00+14.32%
7/23/2021Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetUnderweight$32.00 ➝ $36.00-0.17%
6/15/2021Argus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy$34.00 ➝ $39.00+10.48%
5/20/2021Berenberg Bank
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeHold ➝ Buy
12/15/2020Smith Barney Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost Target$28.00 ➝ $30.00+2.28%
12/14/2020KeyCorp
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeOverweight ➝ Sector Weight
11/4/2020Raymond James
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingBuy
9/1/2020Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageBuy$31.00+12.89%
5/22/2020BMO Capital Markets
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingBuy$30.00+23.86%
(Data available from 12/6/2017 forward. View 10+ years of historical ratings with our analyst ratings screener.)












PEAK Price Target - Frequently Asked Questions

What is Healthpeak Properties's consensus rating and price target?

According to the issued ratings of 11 analysts in the last year, the consensus rating for Healthpeak Properties stock is Hold based on the current 6 hold ratings and 5 buy ratings for PEAK. The average twelve-month price prediction for Healthpeak Properties is $31.27 with a high price target of $40.00 and a low price target of $23.00. Learn more on PEAK's analyst rating history.

Do Wall Street analysts like Healthpeak Properties more than its competitors?

Analysts like Healthpeak Properties more than other Finance companies. The consensus rating score for Healthpeak Properties is 2.45 while the average consensus rating score for finance companies is 2.45. Learn more on how PEAK compares to other companies.

Do MarketBeat users like Healthpeak Properties more than its competitors?

MarketBeat users like Healthpeak Properties less than other Finance companies. 43.90% of MarketBeat users gave Healthpeak Properties an outperform vote while finance companies recieve an average of 62.08% outperform votes by MarketBeat users.

Is Healthpeak Properties being upgraded by Wall Street analysts?

Over the previous 90 days, Healthpeak Properties's stock had 2 upgrades by analysts.

Does Healthpeak Properties's stock price have much upside?

According to analysts, Healthpeak Properties's stock has a predicted upside of 12.11% based on their 12-month price targets.

What analysts cover Healthpeak Properties?

Healthpeak Properties has been rated by Barclays, Evercore ISI, Morgan Stanley, and Wolfe Research in the past 90 days.


Stock Ratings Reports and Tools

This page (NYSE:PEAK) was last updated on 12/6/2022 by MarketBeat.com Staff